Cargando…
Current perspectives on combination therapy in the management of hypertension
Hypertension (HTN) is a worldwide health problem and a major preventable risk factor for cardiovascular (CV) events. Achieving an optimal blood pressure (BP) target for patients with HTN will often require more than one BP-lowering drug. Combination therapy is not only needed, but also confers many...
Autores principales: | Mallat, Samir G, Itani, Houssam S, Tanios, Bassem Y |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3699293/ https://www.ncbi.nlm.nih.gov/pubmed/23837009 http://dx.doi.org/10.2147/IBPC.S33985 |
Ejemplares similares
-
Free versus Fixed Combination Antihypertensive Therapy for Essential Arterial Hypertension: A Systematic Review and Meta-Analysis
por: Mallat, Samir G., et al.
Publicado: (2016) -
Rituximab use in adult primary glomerulopathy: where is the evidence?
por: Mallat, Samir G, et al.
Publicado: (2016) -
Carbonic anhydrase inhibitors in patients with respiratory failure and metabolic alkalosis: a systematic review and meta-analysis of randomized controlled trials
por: Tanios, Bassem Y, et al.
Publicado: (2018) -
What is a preferred angiotensin II receptor blocker-based combination therapy for blood pressure control in hypertensive patients with diabetic and non-diabetic renal impairment?
por: Mallat, Samir G
Publicado: (2012) -
Valsartan combination therapy in the management of hypertension – patient perspectives and clinical utility
por: Nash, David T, et al.
Publicado: (2009)